在炎症性肠道疾病中减缓组合疗法的指南:回顾性队列研究
Adam A Saleh1, Rajdeepsingh Waghela2, Shayan Amini2
1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Crohn's & colitis 360
|May 5, 2025
概括
对于正在缓解的炎症性肠病 (IBD) 患者来说,坚持降级计划是关键. 不遵守的情况显著增加了对组合生物疗法的重新升级的需求.
科学领域:
- 胃肠病学 胃肠病学
- 临床药理学 临床药理学
- 免疫学 免疫学 免疫学
背景情况:
- 先进的组合疗法 (生物药物和小分子) 越来越多地用于炎症性肠病 (IBD).
- 关于在实现疾病缓解后有效缓解组合治疗的数据有限.
- 这项研究评估了中心对降低IBD复合疗法的方法.
研究的目的:
- 评估IBD患者减缓结合疗法的结果.
- 确定影响需要重新升级后降级的因素.
- 分析降级战略的安全性和有效性.
主要方法:
- 对50名IBD患者进行综合疗法缓解的回顾性研究 (2017年5月-2023年3月).
- 基于降级方法,坚持和患者特征的重新升级,类固醇使用和住院率的比较.
- 疾病活动测量和后续数据的分析.
主要成果:
- 12%的患者需要重新升级治疗; 76%的患者维持或进一步降低治疗.
- 对降级计划的不遵守与重新升级的需要有很强的相关性 (P < .001).
- 在IBD再次升级后,没有患者需要住院治疗,尽管25%需要全身类固醇.
结论:
- 患者的坚持和先前的生物失败是重新升级的风险因素.
- 降级策略的成功与坚持相关,而不是特定的药物 (生物或JAK抑制剂).
- 需要进一步的研究来优化IBD患者缓解症状的缓解方案.
相关概念视频
Chronic Bowel Disorders: Introduction
900
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
Drugs for Treatment of Diarrhea-Predominant IBS
1.0K
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
Drugs for Treatment of Ulcerative Colitis in IBD
705
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
705
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
755
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
755
Irritable Bowel Syndrome III: Medical and Nursing Management
989
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
989
Inflammatory Bowel Disease V: Surgical Management
917
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
917


